Akbar Ali Khan Pathan

Akbar Ali Khan Pathan

Auto-generated profile, based on publicly available information

Akbar Ali Khan Pathan

MGI Tech. Co. Ltd, Shenzen-518083, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Disease Markers
Verified
Journal Article
Open access
PDF file
FAFatima AlMutairi
Fatima AlMutairi
APAkbar Ali Khan Pathan
Akbar Ali Khan Pathan
MAMohammed Alanazi
Mohammed Alanazi
MSManal Shalaby
Manal Shalaby
HAHuda A. Alabdulkarim
Huda A. Alabdulkarim
NRNarasimha Reddy
Narasimha Reddy
Objective. The aim of this study was to investigate the role of APE1 Asp148Glu polymorphism in breast cancer progression in Saudi population.Methods. We examined the genetic variations (rs1130409) in the DNA base excision repair gene APE1 at codon 148 (Asp148Glu) and its association with breast cancer risk using genotypic assays andin silicostructural as well as functional predictions.In silicostructural analysis was performed with Asp148Glu allele and compared with the predicted native protein structure. The wild and mutant 3D structures of APE1 were compared and analyzed using solvent accessibility models for protein stability confirmation.Results. Genotypic analysis of APE1 (rs1130409) showed statistically significant association of Asp148Glu with elevated susceptibility to breast cancer. Thein silicoanalysis results indicated that the nsSNP Asp148Glu may cause changes in the protein structure and is associated with breast cancer risk.Conclusion. Taken together, this is the first report that established that Asp148Glu variant has structural and functional effect on the APE1 and may play an important role in breast cancer progression in Saudi population.

9 March 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
JSJilani Purusottapatnam Shaik
Jilani Purusottapatnam Shaik
IAIbrahim O. Alanazi
Ibrahim O. Alanazi
APAkbar Ali Khan Pathan
Akbar Ali Khan Pathan
NRNarasimha Reddy
Narasimha Reddy
MAMajid A. Almadi
Majid A. Almadi
ZKZahid Khan
Zahid Khan
Colorectal cancer is a major health concern as it ranks third in incidence and second major cause of cancer-related deaths worldwide. A leading cause of treatment failure has been attributed to cancer stem cells that can invariably resist existing chemotherapeutic regimens. Notch signaling pathway has been involved in the maintenance of stem cells besides being crucial in cell fate decision and embryonic development. This pathway has also been implicated in several human malignancies including colorectal cancer. We investigated mRNA expression of four Notch receptors (Notch1–4), five ligands (Jag1, Jag2, Dll1, Dll3, and Dll4), and four target genes (Hes1, Hes5, Hey1, and Hey2) using highly specific TaqMan gene expression assays in colorectal adenomas and cancers. Upregulated expression of Notch receptors ranged between 29 and 73% in colorectal cancers and between 11 and 56% in adenomas. Expression of Notch3 and Notch4 receptors was significantly higher in colorectal cancers compared to normal and adenoma tissues. The Jagged and Delta-like ligands were overexpressed between 25 and 52% in colorectal cancers, while in adenomas, it ranged between 0 and 33%. Combining the data for upregulation of receptors and ligands suggests that 86% colorectal cancers and 56% adenomas exhibited overexpression of Notch pathway genes in our cohort. Notch target genes were upregulated between 24 and 33% in colorectal cancers and between 11 and 22% in adenomas. Collating upregulation of Notch receptors and ligands with the target genes showed concordance in 58% colorectal tumors. Additionally, we evaluated expression of Notch receptors, ligands, and target genes with prognosis using the TCGA mRNA expression dataset. Patients overexpressing Notch3, Notch4, and Hey1 had significantly poorer overall survival relative to those having lower levels of these genes. Taken together, Notch signaling components are aberrantly overexpressed in colorectal tumors, and development of therapeutics targeting the Notch pathway may prove to be beneficial in the management of colorectal cancers.

30 June 2023 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
MBMeraj Banu
Meraj Banu
APAkbar Ali Khan Pathan
Akbar Ali Khan Pathan
KCK. V. Chaitanya
K. V. Chaitanya
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.

19 September 2022 in Asian Journal of Chemistry
Verified
Journal Article
Open access
SAS.S. Achar
S.S. Achar
LPL. Pethakamsetty
L. Pethakamsetty
APA.A. Pathan
A.A. Pathan
NRNarasimha Reddy
Narasimha Reddy
SVSaisha Vinjamuri
Saisha Vinjamuri
With the increase in medical pandemics caused by emerging and re-emerging microbial pathogens, topping multi drug resistance, there is always a dire requirement for the novel drugs to treat diseases. In view of the imperative need for lead molecules addressing ailments, the authors have extended their phytochemical studies on the crude extracts of Exacum bicolor Roxb, to in silico ADME analysis followed by in vitro screening for biological activities. In present study, the crude extracts of E. bicolor are subjected to GC-MS analysis and a total of 32 phytoconstituents were identified and considered for ADME analysis by Swiss ADME software. This study represents the first-time reports on the in silico screening of the plant extracts of Exacum bicolor. Further preliminary screening of the crude extracts displayed moderate antioxidant, cytotoxic, antibacterial and antifungal properties, which might be due to the presence of phenolic and alkaloid derivatives.